Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline (1)
- Na+ specifically modulates GPCR signaling in Opioid receptors
- Mutations in Na+ pocket abolish A2AAR signaling
- Mutations in sodium pocket lead to biased “efficacy switches” in δ-Opioid Receptor
- Na+ plays a key role in activation mechanism
- Outline (2)
- Sodium ion dynamics in Opioid receptors
- But where does it go upon activation?
- Is protonation of D2.50 involved in sodium transition?
- Protonation changes Na+ potential along the path
- Na+ ion egress to the intracellular side.
- Updated Na+ mechanism
- Outline (3)
- Stabilizing mutations in conserved Na+ site
- Allosteric Na+ pocket – practical applications
- Allosteric binding of Amiloride derivatives
- Design bitopic ligands to modulate G-protein bias
- Morphinan-based bitopic ligands
- Bitopic ligands show biased signaling profile
- Leukotriene receptor BLT1 binds bitopic ligand
- Summary & outlook
- Acknowledgements
Topics Covered
- Na+ dynamics in GPCR signaling
- Mutations in Na+ pocket
- Protonation changes
- Allosteric Na+ pocket
- Bitopic ligands
Links
Series:
Categories:
Talk Citation
Katritch, V.“. (2019, December 31). Conserved allosteric sodium in class A GPCRs: Na+ dynamics in GPCR signaling [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/CWES1709.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Vsevolod “Seva” Katritch has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Conserved allosteric sodium in class A GPCRs: Na+ dynamics in GPCR signaling
Published on December 31, 2019
24 min
Other Talks in the Series: G Protein-Coupled Receptors (GPCRs) Signaling in Health and Disease
Transcript
Please wait while the transcript is being prepared...
0:05
So returning to outline,
we see that sodium is highly conserved in class A GPCRs,
brazenly highly conserved, We see that it participates as
a switch in the conformational changes upon activation on the receptor.
So it is highly involved in function of receptor and revolution conserve dysfunction.
So it suppose to be very important for the whole family.
Now that we have put aside that sodium was a key factor in GPCRs signaling mechanism.
0:42
There are some indications,
again from both physical studies,
biochemical studies in vitro.
In this particular work from year 2,000.
It shows that first of all,
increasing concentration of sodium decreases quite profoundly the basal attitudes.
So it stops receptor from spontaneous signaling and on the bottom panel
it also show that it actually enhances or
promotes the response of the receptor to full agonists.
In this particular case,
for the Mu Opioid receptor,
basically, if you look at the zero concentration of sodium,
there is almost no difference in full agonists and partial agonists simulation
of GTPS binding and while the sodium concentration increases,
it allows to differentiate that into full agonists and partial agonists,
through which indicates that presence of
sodium modulates and enhances signaling effects of wagons.
This is from earlier study as well comparing
all basal activity with full agonists and antagonists signaling,
in this case in GTPs activity.
What is important in this experiment,
it was done with keeping down extreme the same and exchanging sodium to potassium.
What happens is with increase concentration of sodium,
the basal activity dramatically reduce that we've seen in the previous example.
But full agonists signaling does not.
So again, it differentiates between basal activity and the full agonist activity.
So it enhances the signaling by the full agonists.
Hide